Teenage Cancer Trust
Ovarian Cancer Action
- Contributing research to:
- I have a BRCA1/2 gene mutation: Everything you need to know about BRCA1/2 gene mutations for England and Wales
- I have ovarian cancer: Everything you need to know about BRCA1/2 gene mutations for England and Wales
- I'm worried about my family history of cancer: Everything you need to know about BRCA1/2 gene mutations for England and Wales
- I have a BRCA1/2 gene mutation: Everything you need to know about BRCA1/2 gene mutations for Scotland
- I have ovarian cancer: Everything you need to know about BRCA1/2 gene mutations for Scotland
- I'm worried about my family history of cancer: Everything you need to know about BRCA1/2 gene mutations for Scotland
- BRCA1/2 gene testing and Ovarian Cancer: The UK picture 2014 Oct 2014
- The Economics of Expanding BRCA1/2 testing to women diagnosed with Ovarian Cancer: What do we know? Feb 2014
- Cancer52 response to NICE and NHS England consultation on proposal for changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE's Technology Appraisal and Highly Specialised Technologies programmes Jan 2017
- Cancer52 Speaking up for patients: Patient organisation involvement in Health Technology Assessment with a focus on Patient and Clinical Engagement at the Scottish Medicines Consortium Dec 2015 and a summary here
- Cancer52 response to NHS England consultation on proposed changes to the Standard Operating Procedures of the Cancer Drugs Fund 2015/16 and a summary here
- Cancer52 response to NHS England consultation on Investing in Specialised Services April 2015 and an overview here
- Cancer52 response to NICE consultation on the Guide to the Methods of Technology Appraisals (also known as Value Based Assessment or VBA) Jun 2014 and an overview here
- Cancer52 briefing paper on access to orphan medicines in the UK, More deliberation and less maths, June 2014
- Cancer52 response to NICE consultation on Technology Appraisals Process Guide Mar 2014 and an overview here
- Cancer52 briefing paper on the UK Strategy for Rare Diseases, Making sure that rare cancers aren't written out of the script Feb 2014
- Cancer52 briefing paper on NICE and Value Based Assessment (VBA), NICE and Value Based Assessment (VBA) - NICE do it their way Feb 2014
- Cancer52 Position Statement on Value Based Pricing (VBP): September 2013 Update, Sept 2013
- Cancer52 Position Statement on the Cancer Drugs Fund in England Sept 2013
- Cancer52 Position Statement on Value Based Pricing 2012
- Cancer52 Viewpoints on VBP and CDF: 60 second interviews with Eric Low, Dave Ryner and Leela Barham Sept 2013
Breast Cancer Now and Prostate Cancer UK
Heart Valve Voice
- Breast Cancer Now and Prostate Cancer UK drew on my research for their report, International Comparisons of Health Technology Assessment Aug 2016
Heart Valve Voice
CRA International
World Heart Federation
World Heart Federation
- Urbanization and Cardiovascular Disease: Raising Heart-healthy Children in Today's Cities The World Heart Federation 2012
- Work and Health Decision Making in Europe - Case Studies from Eight European Countries and Brazil Fit for Work European Coalition 2012
- The Place of Work in Health Care Decision Making Fit for Work European Coalition 2011
- Fit for Work? Musculoskeletal Disorders in the European Workforce The Work Foundation 2009
FirstWord
- Building Effective Health Economics Outcomes Research Teams FirstWord 2016
- Payer Perspectives on Risk Sharing Deals FirstWord 2015
- Payer Agreements: Splitting the Risk FirstWord 2011
- Health Technology Assessment: A European Perspective FirstWord 2011
- Atrial Fibrillation in Europe: How AWARE Are You? SAFE and the World Heart Federation 2010
BUPA, Rand Europe, C3 Collaborating for Health and The Work Foundation
- Healthy Work: Evidence into Action BUPA 2009 and Technical Appendix
- Healthy Work: Opportunities and Challenges to 2030 BUPA 2009
For transparency, I received payment for all of these reports.
